← Company intelligence

Robot maker · registered

Chemify

Corporate marketlabmanufacturingCurated record

Chemify has built a proprietary modular robotics platform driven by χDL, a universal chemical programming language that translates molecular designs into executable robot instructions. The ASSEMBLER route-optimisation engine selects validated reaction pathways and dispatches them to in-house robotic synthesisers. The entire chemputation stack — including the robotics hardware — is maintained in-house, with engineering and fabrication zones at the Glasgow Chemifarm used to prototype next-generation hardware. The Chemifarm, opened July 2025, runs hundreds of robots in a closed-loop AI-driven synthesis and characterisation cycle.

HeadquartersGlasgow, GB
Founded2022
Corporate funding$107M
TeamNot listed
Deployments3
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries B
FoundersLee Cronin (Founder & CEO)
Regions servedEurope, North America
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-14
MX

Robot models

Specifications remain vendor-claimed

Machinelab

Chemifarm Synthesis Platform

  • World's first Chemputation facility; industrial-scale robotic synthesis of small molecules

    Fully automated facility combining AI molecular design with proprietary modular robotic synthesisers

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2026-02-12Zeon Corporationmaterials chemistry synthesis collaborationJPNot disclosedAnnouncement
2024-01-18Prepaire Labspharma discovery collaboration (opioid/non-addictive pain)USNot disclosedAnnouncement
2023-09-14Dewpoint Therapeuticspharma discovery collaborationUSNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordTriatomic CapitalBlueYard CapitalHorizon VenturesInsight PartnersWing Venture Capital8VC
TL

Company timeline

Milestones and announcements

2025-10-01Raised $50M+ Series B led by Wing Venture Capital and Insight Partners for global expansionBusiness Wire
2025-07-01Chemifarm opened in Glasgow: £12M facility described as world's first Chemputation site, running AI-directed robotic synthesis at industrial scaleGlasgow City of Science and Innovation
2023-08-01Raised $43M Series A led by Triatomic Capital to digitise chemistry and scale robotic synthesisBusiness Wire
SC

Source ledger

8 unique public sources